ArticleIntensive care medicine experimental2026
Confocal laser endomicroscopy in patients with acute respiratory failure.
Article in Intensive care medicine experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSurvivors of the early exudative phase of acute respiratory distress syndrome (ARDS) may develop a fibroproliferative repair response and persistent microstructural remodeling associated with adverse outcomes. Conventional imaging, including chest computed tomography (CT), has limited biological specificity for early microscopic remodeling. Confocal laser endomicroscopy (CLE) enables real-time bronchoscopic imaging of the alveolar compartment with near-histologic resolution. We evaluated the feasibility and safety of bedside bronchoscopic CLE in invasively ventilated ICU patients with acute respiratory failure and explored whether in vivo CLE provides microscopic alveolar information complementary to chest CT.
methodsIn this single-center observational pilot study, mechanically ventilated adult ICU patients with a clinical indication for bronchoalveolar lavage (BAL) underwent additional bedside bronchoscopic CLE. Primary endpoints were feasibility (≥ 1 interpretable alveolar video with visible septal architecture per procedure) and safety (CLE-related adverse events within 24 h). Secondary exploratory endpoints were dominant in vivo CLE patterns of alveolar filling (air, fluid, cells) and architecture (thin elastin fibers with hexagonal architecture; increased elastin with preserved architecture; increased elastin with distortion) and qualitative comparison with CT abnormalities in the imaged segments. As an exploratory additional analysis, ex vivo CLE was performed in a single autopsy case and compared with histopathology.
resultsA total of 33 patients were included (median age 64 years; 61% male); 31/33 met Berlin ARDS criteria. Forty-one CLE procedures were performed, all yielding high-resolution alveolar imaging (procedural feasibility 100%). A total of 150 videos were acquired (mean acquisition time 46 s per video), with a mean of three bronchial segments imaged per procedure. No CLE-related adverse events occurred. Patterns that were recognized by CLE were: alveolar filling with air (n = 94, 63%), fluid (n = 18, 12%), cells (n = 38, 25%); alveolar architecture was described as thin elastin fibers with hexagonal architecture (n = 37; 25%), increased elastin fibers with preserved architecture (n = 80; 53%) or distorted architecture (n = 29; 19%). Architecture was undeterminable in 4 (3%) videos. CLE detected abnormalities in 6/7 CT-normal appearing segments and demonstrated architectural changes in 60/78 segments with ground-glass opacities. In the autopsy case, ex vivo CLE was concordant with histopathology: regions with increased and distorted CLE signal corresponded to thickened alveolar septa and fibrotic remodeling.
conclusionBedside bronchoscopic CLE is feasible and safe in mechanically ventilated ICU patients with ARDS. CLE provides complementary microscopic information on alveolar filling and architecture beyond chest CT, including features compatible with early structural remodeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.